Zocto News
News

Revolutionizing Cancer Diagnosis: The Rise of Next-Gen Sequencing

June 23, 2026
Revolutionizing Cancer Diagnosis: The Rise of Next-Gen Sequencing
9 views
AI Summary

Next-generation sequencing offers precise cancer treatment, now accessible to Indian lung cancer patients through the LuNGS Alliance.

## Introduction to Next-Generation Sequencing
Next-generation sequencing (NGS) represents a significant breakthrough in cancer diagnostics, offering a personalized approach to treatment by identifying specific genetic mutations in patients. This genomic test allows for targeted therapies, drastically improving patient outcomes and quality of life.

## A Case Study: Sita Devi's Journey
Sita Devi, an 80-year-old patient, experienced severe symptoms due to stage-4 lung cancer that had metastasized to her brain. Traditional treatment would have involved a biopsy and radiation, with palliative care as the final recourse. However, through NGS, doctors identified an EGFR mutation in her cancer cells. This allowed for treatment with osimertinib, a targeted therapy, rather than standard chemotherapy. As a result, Devi has significantly improved and can now walk independently.

## The Impact of NGS in Cancer Treatment
NGS is transforming how doctors approach cancer treatment by enabling decisions based on cellular characteristics rather than a one-size-fits-all method. Medical oncologist Dr. Surendra Beniwal highlights that NGS can lead to better disease control and longer patient survival. Another example is a young woman with stage-two breast cancer, who benefited from targeted treatment and avoided the harsh side effects of chemotherapy.

## Making NGS Accessible in India
Despite the promise of NGS, its high cost has limited accessibility. The LuNGS Alliance seeks to change this by providing free NGS testing for lung cancer patients in India, demonstrating how medical advancements can be made affordable.

## The Future of Precision Medicine
Hitesh Goswami, CEO of 4baseCare, emphasizes that the future of disease management lies in understanding individual genetic data to tailor treatments. With over 4 million people gene-mapped globally, the potential applications of NGS data are vast. Companies like Illumina and pharmaceutical giants such as GSK are investing heavily in this technology, aiming to develop precision drugs.

## Conclusion
NGS is revolutionizing cancer diagnosis and treatment, offering hope for a future where precision medicine is the norm. As more data becomes available and collaborations like the LuNGS Alliance expand, the benefits of NGS will become increasingly accessible, transforming patient care worldwide.

9 views